Anders Olof Adolf Ekblom
Président chez XSPRAY PHARMA AB
Fortune : 152 058 $ au 31/05/2024
Provenance du réseau au premier degré de Anders Olof Adolf Ekblom
Entité | Type d'entité | Industrie | |
---|---|---|---|
154
| Public Company | Pharmaceuticals: Major | 154 |
Karolinska Institutet
95
| College/University | Other Consumer Services | 95 |
Public Company | Biotechnology | 33 | |
Public Company | Biotechnology | 31 | |
28
| Public Company | Pharmaceuticals: Major | 28 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
20
| Subsidiary | Miscellaneous Commercial Services | 20 |
Public Company | Pharmaceuticals: Major | 16 | |
Public Company | Pharmaceuticals: Major | 10 | |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
9
| Holding Company | Biotechnology | 9 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden.
7
| Holding Company | Packaged Software | 7 |
Modul 1 Data AB
Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden.
7
| Subsidiary | Information Technology Services | 7 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.
7
| Subsidiary | Investment Managers | 7 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital.
5
| Non-Profit Organization | Hospital/Nursing Management | 5 |
Vetenskapsrådet
3
| Private Company | 3 | |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Forska Sverige
Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services.
2
| Private Company | Miscellaneous Commercial Services | 2 |
XSpray Pharma Futurum AB
1
| Subsidiary | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Anders Olof Adolf Ekblom via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Investment Committee Member Chief Executive Officer Director/Board Member Private Equity Investor | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Director/Board Member Director/Board Member Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
MEDA AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Corporate Officer/Principal | |
BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Director/Board Member | |
Knut och Alice Wallenbergs Stiftelse | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | President Chief Executive Officer Director/Board Member | |
RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Founder Director/Board Member Corporate Officer/Principal | |
OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer | |
Chalmers University of Technology | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Uppsala | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
Royal Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Graduate Degree | |
University of Lund | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
LEO Fondet
LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
University of Gothenburg | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
IMMUNOVIA AB | Pharmaceuticals: Major | Founder Director/Board Member Investor Relations Contact | |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Ericsson AB
Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Information Technology Services | Chairman Corporate Officer/Principal | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Chief Operating Officer Comptroller/Controller/Auditor | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
MENDUS AB | Biotechnology | Director/Board Member Chairman Investor Relations Contact Director/Board Member | |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Founder Director/Board Member Director/Board Member | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Medivir Personal AB | Director/Board Member Director/Board Member Director/Board Member | ||
A Bioscience Incentive AB | Chairman Chairman Director/Board Member | ||
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Founder | |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
LEO Holding A/S (Denmark)
LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Director/Board Member | |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member |
Statistiques
Internationale
Suède | 35 |
Royaume-Uni | 8 |
Danemark | 5 |
Etats-Unis | 4 |
Israël | 2 |
Sectorielle
Health Technology | 30 |
Consumer Services | 7 |
Commercial Services | 7 |
Finance | 5 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 770 |
Corporate Officer/Principal | 235 |
Chairman | 217 |
Independent Dir/Board Member | 165 |
Chief Executive Officer | 123 |
Relations les plus connectées
- Bourse
- Insiders
- Anders Olof Adolf Ekblom
- Connexions Sociétés